LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio sat down with new Member Bon Vivant, to learn more about the future of alternative dairy proteins

21/09/2022
INTERVIEW

About Stéphane Mac Millan
An entrepreneur at heart, Stéphane has participated in the launch and scale up of two start-ups in Europe. He also worked in strategic consulting before the launch of Bon Vivant.

Interview with... Stéphane Mac Millan, Co-Founder & CEO at Bon Vivant

1) What inspired the foundation of Bon Vivant?
When I turned 30 years old, I decided that my next entrepreneurial endeavour would have to meet two criteria i) help tackle at least one of the major issues our generation is facing ii) have an impact at a large scale. When I discovered that if we applied precision fermentation to dairy proteins it would have a positive impact on the environment, animal welfare and human health and all of these at an industrial level, I simply got obsessed about creating a European champion.

2) What potential do you see in demand for alternative dairy products?
Dairy products are simply one of the best sources of proteins. Besides, the diversity of dairy products (e.g., cheese, yogurts, ice cream, chantilly, etc.) makes it a major part of most human being alimentation. But the problem is that the way we are producing the milk necessary for our dairy products is simply not sustainable and it will only become worst with the growing population. Therefore, we absolutely need to invent new complementary way of production.

3) What are your plans for growth?
We are building our portfolio of animal-free milk proteins and ready-mix. The objective is to be the most innovative dairy ingredients provider to serve the demand of dairy manufacturers and help them recreate their iconic products and also invent new ones.

4) How do you see Bon Vivant being able to transform the dairy industry's impact on climate change and animal welfare?
We are working hand in hand with dairy manufacturers to understand their needs and create for them the solutions they want. We are lucky to partner with some of the major players in the world. So, if only we could answer 10% of their needs in animal-free milk proteins, then our impact would be colossal, and our mission fulfilled.

Interview with Bon Vivant


Download
2022_09_G_O_Interview-with-Bon-VivantDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

10/06/2025

EuropaBio Position on the EU Biotech Act: Prosperity, resilience and leadership for the European Union


Read more
10/06/2025

The EU economic and scientific future starts with the EU Biotech Act


Read more
05/06/2025

The GPL must include biotech & life science to unleash EU innovation


Read more

Important links

  • EuropaBio Position on the EU Biotech Act: Prosperity, resilience and leadership for the European Union
  • The EU economic and scientific future starts with the EU Biotech Act

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.